Browse the corpus

REFERENCES Bell AD, Roussin A, Cartier R, et al, “The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines,” Can J Cardiol , 2011, 27(Suppl A):1-59. [PubMed 21640290 ] Capone ML, Sciulli MG, Tacconelli S, et al, “Pharmacodynamic Interaction of Naproxen With Low-Dose Aspirin in Healthy Subjects,” J Am Coll Cardiol , 2005, 45(8):1295-1301. [PubMed 15837265 ] Catella-Lawson F, Reilly MP, Kapoor SC, et al, “Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin,” N Engl J Med , 2001, 345(25):1809-17. [PubMed 11752357 ] Cryer B, Verlin RG, Cooper SA, et al, “Double-Blind, Randomized, Parallel, Placebo-Controlled Study of Ibuprofen Effects on Thromboxane B2 Concentrations in Aspirin-Treated Healthy Adult Volunteers,” Clin Ther , 2005, 27(2):185-191. [PubMed 15811481 ] Dixon BS, Beck GJ, Vazquez MA, et al, “Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency,” N Engl J Med , 2009, 360(21):2191-201. [PubMed 19458364 ] Guyatt GH, Akl EA, Crowther M, et al, “Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,” Chest , 2012, 141(2 Suppl):7-47. [PubMed 22315257 ] Smith SC Jr, Benjamin EJ, Bonow RO, et al, “AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update: A Guideline From the American Heart Association and American College of Cardiology Foundation,” Circulation , 2011, 124(22):2458-73. [PubMed 22052934 ] Topic 8664 Version 41.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [1002-61.234.146.186-C3C4DA4C00-S244013.14]